Pascal and Francis Bibliographic Databases


Search results

Your search



A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 19040

  • Page / 762

Selection :

  • and

Effect of zonisamide on lipid peroxidationKOMATSU, M; HIRAMATSU, M; ENDO, A et al.Neurosciences (Okayama). 1995, Vol 21, pp P63-P66, issn 0388-7448, SUPConference Paper

Clinical pharmacology of lamotriginePECK, A. W.Epilepsia (Copenhagen). 1991, Vol 32, pp S9-S12, issn 0013-9580, SUP2Conference Paper

Neurochemical and behavioral aspects of lamotrigineLEACH, M. J; BAXTER, M. G; CRITCHLEY, M. A. E et al.Epilepsia (Copenhagen). 1991, Vol 32, pp S4-S8, issn 0013-9580, SUP2Conference Paper

Prevention of hyperthermia-induced seizures in immature rats by a hydantoin derivative of naloxoneCHATTERJIE, N; LAORDEN, M. L; PUIG, M. M et al.Life sciences (1973). 1989, Vol 45, Num 10, pp 857-862, issn 0024-3205, 6 p.Article

Anticonvulsant phosphorus analogs of GABACATES, L. A.Drug development research. 1985, Vol 5, Num 4, pp 395-399, issn 0272-4391Article

Pharmacological evaluation of various metabolites and analogues of valproic acidLOSCHER, W; NAU, H.Neuropharmacology. 1985, Vol 24, Num 5, pp 427-435, issn 0028-3908Article

When the antiepileptic drugs are not workingLEACH, John Paul.Practical neurology (Print). 2009, Vol 9, Num 1, pp 27-32, issn 1474-7758, 6 p.Article

Human safety of lamotrigineBETTS, T; GOODWIN, G; WITHERS, R. M et al.Epilepsia (Copenhagen). 1991, Vol 32, pp S17-S21, issn 0013-9580, SUP2Conference Paper

Overview of the clinical efficacy of lamotrigineRICHENS, A; YUEN, A. W. C.Epilepsia (Copenhagen). 1991, Vol 32, pp S13-S16, issn 0013-9580, SUP2Conference Paper

Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiencyGIBSON, K. M; DEVIVO, D. C; JAKOBS, C et al.Lancet (British edition). 1989, Vol 2, Num 8671, pp 1105-1106, issn 0140-6736, 2 p.Article

Zur Valenz leistungspsychologischer Parameter bei Einstellung auf Finlepsin und convulsofin = Paramètre psychologique de l'efficacité de la finlepsine et de la convulsofine = For valence by the introduction of finlepsin and convulsofin of efficiency psychological parameterKONIG, K; TSCHUSCHKE, D.Psychiatrie, Neurologie und medizinische Psychologie. 1987, Vol 39, Num 1, pp 44-48, issn 0033-2739Article

Binding of sulfonamides to erythrocytes and their componentsMATSUMOTO, K; MIYAZAKI, H; FUJII, T et al.Chemical and pharmaceutical bulletin. 1989, Vol 37, Num 7, pp 1913-1915, issn 0009-2363, 3 p.Article

The influence of carbamazepine on the heme biosynthetic pathwaySCHOENFELD, N; GREENBLAT, Y; EPSTEIN, O et al.Biochemical medicine. 1985, Vol 34, Num 3, pp 280-286, issn 0006-2944Article

Surveillance thérapeutique du phénobarbital et de la diphénylhydantoineBAGREL, D; SIEST, G.SYNTHESE MEDICALE. 1987, Num 7, pp 2-7, 2 p.Article

Amphetamine as a protective agent against oxygen-induced convulsions in miceCRIBORN, C. O; CLEMEDSON, C.-J; HENRIKSSON, C et al.Aviation, space, and environmental medicine. 1986, Vol 57, Num 8, pp 777-781, issn 0095-6562Article

Therapeutic monitoring of antiepileptic drugs. II: Analytical techniquesALBANI, F; RIVA, R; BARUZZI, A et al.Il Farmaco (Pavia). 1992, Vol 47, Num 5, pp 671-680, issn 0014-827X, SUPConference Paper

Effects of carbamazepine and its epoxide metabolite on amygdala-kindled seizures in ratsALBRIGHT, P. S; BRUNI, J.Neurology. 1984, Vol 34, Num 10, pp 1383-1386, issn 0028-3878Article

The anticonvulsant and proconvulsant effects of α2-ADRENORECEPTOR agonists are mediated by distinct populations of α2A-ADRENORECEPTORSSZOT, P; LESTER, M; LAUGHLIN, M. L et al.Neuroscience. 2004, Vol 126, Num 3, pp 795-803, issn 0306-4522, 9 p.Article

Acneiform eruption induced by ethosuximideRICCI, Francesco; PARADISI, Andrea; MASINI, Francesco et al.EJD. European journal of dermatology. 2014, Vol 24, Num 1, pp 98-99, issn 1167-1122, 2 p.Article

Anti-epileptic DrugsHOWARD, Paul; TWYCROSS, Robert; SHUSTER, John et al.Journal of pain and symptom management. 2011, Vol 42, Num 5, pp 788-804, issn 0885-3924, 17 p.Article

Phenytoin embryotoxicity: role of enzymatic bioactivation in a murine embryo culture modelSHANKS, M. J; WILEY, M. J; KUBOW, S et al.Teratology (Philadelphia, PA). 1989, Vol 40, Num 4, pp 311-320, issn 0040-3709, 10 p.Article

Description and analysis of the myotonolytic effects of phenytoin in the decerebrate cat: implications for potential utility of phenytoin in spastic disordersRAINES, A; MAHANY, T. M; BAIZER, L et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 232, Num 1, pp 283-294, issn 0022-3565Article

Anticonvulsant hypersensitivity syndromeKAMINSKY, A; MORENO, M; DIAZ, M et al.International journal of dermatology. 2005, Vol 44, Num 7, pp 594-598, issn 0011-9059, 5 p.Article

Drug therapy : New antiepileptic drugsDICHTER, M. A; BRODIE, M. J.The New England journal of medicine. 1996, Vol 334, Num 24, pp 1583-1590, issn 0028-4793Article

Progress report on new antiepileptic drugs. A summary of the Second Eilat ConferenceSTABLES, J. P; BIALER, M; JOHANNESSEN, S. I et al.Epilepsy research. 1995, Vol 22, Num 3, pp 235-246, issn 0920-1211Article

  • Page / 762